期刊文献+

血清肿瘤志物在诊断转移性肺癌中的临床价值 被引量:8

Study on the relation between serum tumor markers and metastatic lung cancer
下载PDF
导出
摘要 目的探讨血清神经元特异性烯醇化酶(NSE)、细胞角蛋白19片段(CYfra21-1)、癌胚抗原(CEA)和乳酸脱氢酶(LDH)在诊断转移性肺癌中的临床价值。方法收集该院肺癌中心收治的331例肺癌患者(肺癌组),另选取201例肺良性病例(肺良性病组)和215例健康体检者(健康组)为研究对象。使用电化学发光和酶法检测所有研究对象NSE、CYfra21-1、CEA和LDH水平,并比较转移性与非转移性肺癌、不同转移组织、不同肺癌分期之间NSE、CYfra21-1、CEA和LDH的水平以及各单项检测和联合检测的效果。结果肺癌组患者NSE、CYfra21-1、CEA和LDH水平均明显高于肺良性病组和健康组,差异有统计学意义(P<0.05);转移性肺癌组NSE、CYfra21-1、CEA和LDH水平明显高于非转移性肺癌组,差异有统计学意义(P<0.05);脑和骨等多处转移组的NSE和CYfra21-1水平明显高于肺内、胸膜和周围淋巴结转移组,差异有统计学意义(P<0.05);肺癌临床Ⅳ期患者的CEA水平明显高于Ⅰ、Ⅱ和Ⅲ期,T3/T4期的NSE、CYfra21-1水平明显高于T1/T2期,差异均有统计学意义(P<0.05);NSE、CYfra21-1、CEA和LDH联合检测的灵敏度明显高于单项检测,差异有统计学意义(P<0.05)。结论转移性肺癌患者血清NSE、CYfra21-1、CEA和LDH水平明显升高,且与肿瘤的转移情况和严重程度相关,联合检测可以明显提高转移性肺癌诊断的灵敏度和特异度,对转移性肺癌的早期诊断、治疗和预后监测评估有重要的临床价值。 Objective To evaluate the clinical value of neuron-specilic enolase (NSE),cytokeratm 19 mg- merits(CYfra21-l) ,serum carcinoembryonic antigen (CEA) and serum lactate dehydrogenase (LDH) to the diagnosis of patients with matastatic lung cancer,and investigate their correlation with metastatic lung cancer. Methods The levels of serum NSE,CEA,CYfra21-1 and LDH were detected in 331 cases of lung cancer pa- tients,201 cases of benign lung disease and 215 individuals of healthy physical examination, by using electro- chemical luminescence and enzymatic methods. Results All the levels of serum tumor markers in patients with lung cancer were significantly higher than those in lung benign disease and individuals of healthy physical ex- amination (P〈0. 05) ;The levels of serum tumor markers in metastatic lung cancer were significantly higher than those in lung cancer without metastasis; The levels of NSE and CYfra21-1 in the patients with brains, bones and multiple metastases were significantly higher than the patients with pulmonary,pleural and periph- eral lymphatic metastasis(P〈0.05). The results of CEA in the clinical stage of IV were higher than those in the clinical stage of Ⅰ-Ⅲ (P〈0.05) ;The results of NSE,CYfra21-1 in the TNM stage of T3/T4 were high- er than those in the TNM stage of T1/T2 (P〈0. 05) ;The sensitivity of combined detection is significantly higher than individual test. Conclusion The four kinds of serum tumor markers were abnormally high levels in patients with metastatic lung cancer, and have positive correlation with the transfer and severity of disease condition. The combined detection of serum markers can significantly improve the detection sensitivity and specificity in the auxiliary diagnosis of lung cancer, and provide reliable clinical predictive value for metastatic lung cancer early diagnosis, treatment and prognosis monitoring.
出处 《检验医学与临床》 CAS 2018年第2期179-182,共4页 Laboratory Medicine and Clinic
关键词 转移性肺癌 神经元特异性烯醇化酶 细胞角蛋白19片段 癌胚抗原 乳酸脱氢酶 metastatic lung cancer neuron-specific enolase ~ cytokeratin 19 fragments ~ carcinoembry-onie antigen lactate dehydrogenase
  • 相关文献

参考文献8

二级参考文献102

  • 1陈允硕,吴健民.肿瘤标志物临床检测的基本原则(建议稿)[J].中华检验医学杂志,2004,27(6):393-393. 被引量:35
  • 2Parkin DM. The evolution of the population-based cancer registry. Nat Rev Cancer 2006,6:603-12.
  • 3National Office for Cancer Prevention and Control, National Center for Cancer Registry, Disease Prevnetion and Control Bureau, MOH. Chinese Cancer Registry Annual Report (2012). Beiiing: Military Medical Science Press, 2012:12.
  • 4Curado MP, Edwards B, Shin HR, et al. Cancer Incidence in Five Continents. Vol. IX. IARC Scientific Publications No.160. Lyon: IARC, 2008:1-837.
  • 5FerlayJ. The IARC crgTools Programs. Avaiable online: http://wwwiacrcomfr/iarccrgtooshtmIACR 2006.
  • 6National Office for Cancer Prevention and Control, National Center for Cancer Registry, Disease Prevnetion and Control Bureau, MOH. Chinese Cancer Registry Annual Report (2011). Beijing: Military Medical Science Press, 2011:12.
  • 7Li GL, Chen WQ. Representativeness of population- based cancer registration in China--comparison of urban and rural areas. Asian Pac J Cancer Prev 2009, 10:559-64.
  • 8Chen WQ, Zheng RS, Zeng HM, et al. Trend analysis and projection of cancer incidence in China between 1989 and 2008. Zhonghua Zhong Liu Za Zhi 2012,34:517-24.
  • 9Zeng HM, Zheng RS, Zhang SW,, et al. Trend analysis of cancer mortality in China between 1989 and 2008. Zhonghua Zhong Liu Za Zhi 2012,34:525-31.
  • 10Schettino C, Bareschino M A, Rossi A, et al, Targeting angiogen?esis for treatment of NSCLC brain metastases [J]. CUIT Cancer Drug Targets, 2012,12(3) :289 -99.

共引文献296

同被引文献93

引证文献8

二级引证文献74

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部